Given that TMCA can promote the GLP-1 production as a natural FXR antagonist 30 , we speculated that TMCA is a major contributor to the T3 effect on GLP-1 and insulin production and glucose homeostasis
This slow increase gives each patient a chance to find the amount that works without causing unpleasant side effects

I am very rookie in this the truth and with a very little idea of type 1 so that something is probably saying something wrong but it would probably have to be monitored closely so that there are no hypos?The truth is that it is helping me although at the moment I only have fasting glucose data.Until 2 weeks I do not have the review with the endocrine to see the A1C But in type 2 DB there is an insulin resistance, and it is the one that produces hyperglycemia.If there is greater resistance..Normally one type 2 has this tto associated with another, it is very rare that it is alone.In any clear case, which lowers glycemia in type 2 PQ there is normally resistance associated with obesity but in type 1 the mechanism is another.You have to inject insulin because we do not have it, you may over time or if it puts weight, there is more insulin resistance but it is rare that the blood glucose decreases alone and if so, then the insulin dose is lowered.There is not much experience in type 1 but it seems that there have been no hypos or imptes side effects

Benefits of Semhil Once-daily oral tablet no injections Helps lower blood sugar and HbA1c Promotes weight loss by reducing appetite Cardiovascular risk reduction in individuals with Type 2 diabetes (based on semaglutide clinical data) Dosage Overview Start with 3 mg once daily for the first 30 days
limited to animal and small pilot studies